Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis

Ann Intern Med. 2005 Dec 20;143(12):918-20. doi: 10.7326/0003-4819-143-12-200512200-00019.
No abstract available

Publication types

  • Letter

MeSH terms

  • Arthritis / drug therapy*
  • Arthritis / etiology*
  • Humans
  • Neoplasm Proteins / therapeutic use*
  • Receptors, Tumor Necrosis Factor, Type II / therapeutic use*
  • Scleroderma, Systemic / complications*
  • Tumor Necrosis Factor Decoy Receptors

Substances

  • Neoplasm Proteins
  • Receptors, Tumor Necrosis Factor, Type II
  • Tumor Necrosis Factor Decoy Receptors